Becton Dickinson falls after co cuts annual profit forecast on potential tariffs

Shares of medical device maker Becton Dickinson BDX.N fall as much as 13.5% to an eight-year low of $179.09

Stock set for its worst day since 1999, if losses hold

BDX cuts annual profit forecast in anticipation of a potential hit from U.S. President Donald Trump's tariffs

Co said it anticipates a $90 million impact from tariffs expense on China, majority of which will be weighted in Q4

Co intends to invest $2.5 billion in U.S. manufacturing capacity over the next 5 years

BDX, which has footprint in Mexico, Europe and Asia, will transfer its manufacturing facilities from China to South Carolina and Nebraska, CEO Thomas Polen said in a conference call

Co expects its 2025 profit per share to be between $14.06 and $14.34, compared with $14.30 to $14.60 previously expected

Co reports Q2 adj profit of $3.35 per share, beating estimates of $3.28

As of last close, BDX had fallen 20.8% YTD